Global treatment pattern variations in HCC

International cancer control plans

Economic impact of NGS in non small cell lung cancer

Subcutaneous daratumumab shows benefit in patients with relapsed or refractory multiple myeloma

Avelumab in combinations for lung cancer and update from ALEX study

Updates in melanoma from ASCO 2018

Novel fusion proteins to target PD-L1 in HPV associated cancers

Daratumumab in combination with carfilzomib and dexamethasone for relapsed multiple myeloma

Phase I study results of M7824 for patients with HPV associated cancers

Phase III results of PROSPECT study for metastatic, castration-resistant prostate cancer

Pancreatic survival improved with trial chemotherapy regimen after surgery

Aspirin combined with acid-reducing medicine offers moderate benefits in patients with Barrett’s oesophagus